New pill tested for diabetes control in japan
NCT ID NCT06869018
Summary
This early-stage study tested a new oral drug called LY3549492 in 92 Japanese adults, including those with type 2 diabetes and healthy volunteers. The main goal was to check the drug's safety, side effects, and how the body absorbs and processes it. Researchers also looked for early signs of whether it could help lower blood sugar and body weight in people with diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Hospital Tokyo
Shinjuku-ku, 160-0004, Japan
-
Hakata Clinic
Fukuoka, 812-0025, Japan
-
Medical Corporation Heishinkai OPHAC Hospital
Osaka, 532-0003, Japan
-
P-One Clinic
Hachiōji, 192-0071, Japan
Conditions
Explore the condition pages connected to this study.